Acknowledgements
The author thanks Professor EA Gould (Oxford/Marseille) and Dr J Tan, Dr L Zhu and Dr Y Kusov (Lübeck) for discussion.
Financial & competing interests disclosure
The author is a member of the three not-for-profit consortia active in antiviral research that have been mentioned in the text: VIZIER, SILVER and ICAV. He has received grants from VIZIER and ICAV in support of his academic research and expects to receive such a grant from SILVER. The author also acknowledges funding for his structural virology and antiviral drug design work from DFG, the European Commission, the Sino-German Center for the Promotion of Research (Beijing), and the Schleswig-Holstein Innovation Fund. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript, apart from those disclosed.
No writing assistance was utlized in the production of this manuscript.